Jiemei Li
Impact in
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
-
- Acupuncture Treatment Research Studies
Papers in
-
- Natural product bioactivities and synthesis 4
-
- Acute Kidney Injury Research 3
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Xiaobin Zeng (11 shared papers)Lanlan Ge (10 shared papers)Haoqiang Wan (10 shared papers)Keda Zhang (8 shared papers)Weigang Wu (8 shared papers)Boping Zhou (5 shared papers)Jinhua Miao (11 shared papers)Lili Zhou (11 shared papers)
- Journals
- Boundary Value Problems (3 papers)Cell Death and Disease (2 papers)Frontiers in Pharmacology (2 papers)Environmental Research (2 papers)Redox Biology (2 papers)
- Partner nations
- ChinaUnited StatesLebanon
In The Last Decade
Jiemei Li
30 papers receiving 430 citations
Peers
Comparison fields: 5 of 86
- Nephrology 60
- Complementary and alternative medicine 62
- Biochemistry 37
- Toxicology 19
- Pharmacology 36
Countries citing papers authored by Jiemei Li
This map shows the geographic impact of Jiemei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiemei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiemei Li more than expected).
Fields of papers citing papers by Jiemei Li
This network shows the impact of papers produced by Jiemei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiemei Li. The network helps show where Jiemei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiemei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 58 | |
| 2 | 2018 | 47 | |
| 3 | 2018 | 41 | |
| 4 | 2019 | 38 | |
| 5 | 2018 | 27 | |
| 6 | 2022 | 27 | |
| 7 | 2018 | 21 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 19 | |
| 10 | 2024 | 19 | |
| 11 | 2020 | 18 | |
| 12 | 2018 | 14 | |
| 13 | 2022 | 13 | |
| 14 | 2024 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2023 | 8 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2025 | 5 | |
| 20 | 2018 | 5 |
About Jiemei Li
Jiemei Li is a scholar working on Molecular Biology, Nephrology, Immunology, Pharmacology and Clinical Biochemistry, having authored 33 papers that have together received 433 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (4 papers), Phytochemistry and Biological Activities (4 papers), Advanced Glycation End Products research (4 papers), Acute Kidney Injury Research (3 papers), Nonlinear Differential Equations Analysis (3 papers), Differential Equations and Numerical Methods (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Renal Diseases and Glomerulopathies (2 papers). The work is most often cited by research in Nephrology (60 citations), Complementary and alternative medicine (62 citations), Biochemistry (37 citations), Toxicology (19 citations) and Pharmacology (36 citations). Jiemei Li has collaborated with scholars based in China, United States and Lebanon. Frequent co-authors include Xiaobin Zeng, Lanlan Ge, Haoqiang Wan, Keda Zhang, Weigang Wu, Boping Zhou, Jinhua Miao, Lili Zhou, Shan Zhou and Shusong Peng. Their work appears in journals such as Boundary Value Problems, Cell Death and Disease, Frontiers in Pharmacology, Environmental Research and Redox Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.